Dr. Soliman Abdel Kader Fakeeh Hospital Company, together with its subsidiaries, establishes, operates, and manages hospitals, clinics, medical, educational, and training centers in the Kingdom of Saudi Arabia. It operates through Medical Services; Education; and Trading, Retail & Others segments. The company offers various services, such as assisted reproductive therapy, audiology, bariatric surgery, pediatric, breast feeding, cardiac surgery, cardiology, chest and respiratory diseases, chiropractic medicine, dental and maxillofacial, dermatology, otorhinolaryngology, endocrinology, ophthalmology, family medicine, gastroenterology, general surgery, geriatric medicine, hematology, hyperbaric oxygen service, infectious diseases, internal medicine, interventional radiology, psychiatry, lasik surgery, nephrology, neuro surgery, neurology, nutrition, obstetrics and gynecology, oncology, orthopedics, pediatric orthopedic surgery, pediatric surgery, physical medicine and rehabilitation, plastic surgery, rheumatology, sleep disorders clinic, speech therapy, thoracic surgery, urology, and vascular surgery, as well as pain treatment and palliative care services. It also operates AIRS, anesthesia, burn, diagnostics service, emergency medicine, endoscopy, intensive care, NICU, renal dialysis, rhinoplasty, and institute of robotic surgery facilities; establishes and manages pharmacies; and provides analysis and radiology laboratory, healthcare, medical education, and home health care services. In addition, the company engages in the trading of pharmaceutical products, spectacles, and cosmetics; construction and contracting; wholesale and retail of medical equipment; and maintenance of IT equipment and software related services. The company was incorporated in 1978 and is based in Jeddah, the Kingdom of Saudi Arabia.
Metrics to compare | 4017 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship4017PeersSector | |
---|---|---|---|---|
P/E Ratio | 36.0x | 23.4x | −0.5x | |
PEG Ratio | −6.81 | 0.46 | 0.00 | |
Price/Book | 3.5x | 3.6x | 2.6x | |
Price / LTM Sales | 3.7x | 4.3x | 2.9x | |
Upside (Analyst Target) | 35.3% | 22.6% | 53.0% | |
Fair Value Upside | Unlock | 13.6% | 8.9% | Unlock |